Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its novel therapy platform, RenovoTAMP™ (RenovoRx Trans-Arterial Micro-Perfusion), will be highlighted during a presentation by expert panelist, Dr. Ripal Gandhi, at the Miami Cancer Institute’s New Advances in the Management of Pancreatic Cancer CME course this evening.
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
RenovoRx today announced its novel therapy platform, RenovoTAMP® (RenovoRx Trans-Arterial Micro-Perfusion), will be highlighted during a presentation by expert panelist, Dr. Ripal Gandhi, at the Miami Cancer Institute’s New Advances in the Management of Pancreatic Cancer CME course this evening.
Potential Future Innovative Strategy for Pancreatic Cancer: Intra Arterial Chemotherapy Presented at Miami Cancer Institute’s New Advances in the Management of Pancreatic Cancer, November 9, 2021
https://renovorx.com/wp-content/uploads/2021/11/Pancreatic-Cancer-Presentation-for-MCI-Pancreas-Symposium-2021-Gandhi.pdf